logo
Why neurologist Guy Leschziner links the seven deadly sins to human biology

Why neurologist Guy Leschziner links the seven deadly sins to human biology

The Hindu2 days ago

Gluttony, greed, sloth, pride, envy, lust and anger are traditionally seen as the root of all evil. But can these undesirable behaviours actually stem from the biology of our brains? Neurologist Guy Leschziner believes so.
Last November, when he launched his book Seven Deadly Sins: The Biology of Being Human, and delved into the neuroscientific and psychological basis of these human tendencies, the London-based professor encouraged much debate. 'The seven deadly sins are woven into the tapestry of what it is to be human,' he later wrote in The Guardian. 'Each of these tendencies, at least in moderation or in specific circumstances, can be seen as a tool for survival.' He went on to say that the origins of the definition of these traits lies in evolutionary imperatives to preserve the tribe and they raise more of a biological question for us than a moral one.
A window into human society
'I was trying to understand how the brain, our biology, influences why we behave badly, and how a better understanding of these processes could actually give us opportunities to make the world a better place,' Leschziner tells The Hindu, on the sidelines of the Kerala Literature Festival 2025. 'I study people at the extremes of the human experience to understand how their brains cause changes in behaviour and how it applies to all of us.'
In the introduction of the book, Leschziner explains how the past 25 years of his life as a practising doctor have offered him a window into human society, allowing him to explore aspects of humanity that few outside the world of medicine can see.
Leschziner's grandfather was himself a victim of the deadly sins: he escaped Nazi Germany with his brother, but their families perished in concentration camps. At his clinic, Leschziner encounters patients from countries like Afghanistan, Syria, and the former Yugoslavia — 'all in London as an outcome of war and upheaval, fruits of human sins'.
A consultant neurologist at the Department of Neurology and Sleep Disorders Centre at Guy's and St Thomas' Hospitals, as well as London Bridge Hospital, the Cromwell Hospital, and One Welbeck, Leschziner is a determinist. 'I believe that everything is a function of the connections within our brain and how it works,' he explains. 'There are factors entirely beyond our control that influence how we behave. For some, it's genetic; for others, it's due to disease or disorder. But, for many, it's shaped by what we're exposed to — either in the womb or later in life — which fundamentally affects how our brains are configured.'
Making sense of sleep
Seven Deadly Sins is Leschziner'sthird book, and has won critical acclaim. However, initially, he had no intention of becoming an author as he was busy with his medical practice. A literary agent, impressed by Leschziner's BBC radio series on the mysteries of sleep, persuaded him to pen his experiences.
Leschziner's first book, The Nocturnal Brain: Nightmares, Neuroscience and the Secret World of Sleep, published in 2019, provided fascinating insights into the sleeping mind, as he drew on case studies of his own patients. The Scientist named it the best neuroscience book of the year, while Forbes termed it one of the must-read books of the year.
He is glad that sleep is finally receiving more attention in medical research. Throughout his remarkable career, Leschziner has helped people manage insomnia, sleep apnoea, restless leg syndrome, and many other sleep disorders.
'When I was in medical school, we were taught nothing at all about sleep; it didn't even figure on the curriculum,' says Leschziner, who was the clinical lead for the Sleep Disorders Centre, Guy's Hospital, one of Europe's largest sleep units, for over a decade. 'There are entire generations of doctors who know nothing about sleep or were never taught its importance. Now we're beginning to understand the far-reaching consequences of poor sleep on our physical, psychological, and neurological health.'
Shortcut to dementia?
He says that getting less than the recommended seven to eight-and-a-half hours of sleep is a growing concern. 'Sleep is crucial for every aspect of our daytime functioning,' says Leschziner. 'We know it's linked to high blood pressure, diabetes, weight gain, and there is increasing evidence that it raises the risk of heart disease and stroke. One major issue, which I believe will affect the entire world in the future, is the connection between sleep and dementia — especially as dementia is becoming more prevalent globally with ageing populations.'
Leschziner is equally intrigued by dreams. 'One of the major mysteries that remains is the function of REM (rapid eye movement) sleep — the stage we most closely associate with dreaming,' he says. 'This stage is crucial for memory consolidation, moving information from the brain's short-term memory circuits to longer-term storage. But REM sleep serves other roles as well; it is probably responsible for regulating our emotions. My own view is that, during sleep, we're essentially creating a model of the world because we need it to make sense of our experiences.'
Though initially hesitant to wield the pen, writing has taken Leschziner into a world beyond the hospital. 'I chose a career in neurology after reading Oliver Sacks' The Man Who Mistook His Wife For A Hat,' he says. 'If my books can inspire even one person to study the brain, I'll be very happy.'
ajithkumar.pk@thehindu.co.in

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UAE Health Ministry ends birth and death certification service: What you need to know
UAE Health Ministry ends birth and death certification service: What you need to know

Time of India

time2 hours ago

  • Time of India

UAE Health Ministry ends birth and death certification service: What you need to know

In a sweeping administrative change, the UAE Ministry of Health and Prevention (MoHAP) has officially ended its role in issuing birth and death certificates. These vital registration services are now handled by Emirates Health Services (EHS) in the northern emirates, while Dubai and Abu Dhabi continue under their respective local health authorities. Tired of too many ads? go ad free now The transition was made quietly, with MoHAP removing all related service options from its website and discontinuing its WhatsApp-based application system. Residents are now required to navigate a decentralised process based on their emirate of residence. What Has Changed? MoHAP has withdrawn from issuing birth and death certificates. Emirates Health Services (EHS) is now responsible in Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah. Dubai Health Authority (DHA) and Abu Dhabi's Department of Health (DoH) continue to manage services locally. (DHA) and Abu Dhabi's Department of Health (DoH) continue to manage services locally. Certificates issued by EHS, DHA, or DoH are fully equivalent to those formerly issued by MoHAP. BIRTH CERTIFICATES: How It Works Now Who Can Apply? Parents (of any nationality), legal guardians, or authorised delegates. Where to Apply? Via the EHS website (requires UAE Pass) Through the Mabrouk Ma Yak platform (for Emiratis only) At EHS public health centres or hospitals Documents Needed: Valid Emirates ID and passport for both parents Hospital-issued, certified birth notification Electronic civil record Marriage certificate or notarised parentage document For UAE citizens with births abroad: Return tickets ID and passports of both parents Attested marriage certificate For complex cases (e.g., prison births): Court-issued documents Letters from correctional facilities or social services Birth notifications Fees & Turnaround (Converted to INR) Birth Certificate in Arabic: AED 65 (~₹1,470) English Copy (optional): AED 65 (~₹1,470) Time to Issue: 1 working day DEATH CERTIFICATES: Procedure and Conditions Who Can Apply? Immediate family members or legally authorised persons. Where to Apply? Through the EHS online portal At a designated public health centre or hospital Documents Required: Emirates ID or passport of the deceased No Objection Certificate (NOC) from Ministry of Interior Official death report In suspicious or unknown-cause deaths: Forensic report Name consistency across all documents is mandatory International Use: Certificates must be attested by the UAE Ministry of Foreign Affairs and International Cooperation and the embassy of the relevant foreign country. Fees & Timelines (Converted to INR) Death Certificate in Arabic: AED 65 (~₹1,470) English Copy (optional): AED 65 (~₹1,470) Time to Issue: 5 minutes for e-certificates Physical copy available upon in-person visit Service Hours Monday to Thursday: 7:30 AM to 3:30 PM Friday: 7:30 AM to 12:00 PM Why the Change Matters The UAE is continuing its trend of devolving administrative authority to regional bodies, particularly for citizen services. Emirates Health Services already manages most public healthcare in the northern emirates, making it a natural successor to MoHAP in handling life-event documentation. The Bottom Line The next time you need a birth or death certificate in the UAE, MoHAP is no longer your go-to authority. Depending on where you live, you'll be interacting with EHS, DHA, or DoH—with new procedures, slightly altered fees, and a greater push toward digital verification. While the transition might be procedural, it signals a larger shift in how civil documentation is administered across the UAE—more digital, more localised, and firmly tied to regional health systems. (Exchange rate used: 1 AED = ₹22.60)

KKR, TPG eye Relisys Medical Devices in early-stage buyout talks
KKR, TPG eye Relisys Medical Devices in early-stage buyout talks

Mint

time2 hours ago

  • Mint

KKR, TPG eye Relisys Medical Devices in early-stage buyout talks

MUMBAI : Relisys Medical Devices is in early-stage discussions with global private equity firms KKR and TPG for a potential ₹1,200–1,300 crore investment, with the transaction likely to offer a full or partial exit to existing investor Siguler Guff, two people familiar with the matter told Mint. 'While TPG is evaluating the company to strengthen its portfolio, KKR is in discussions with the medical devices maker to build out its med-tech platform under which it acquired Healthium Medtech last year from Apax Funds," one of the people cited above said. TPG, too, may look at developing a med-tech platform of its own, the person added. A majority of the proceeds from the transaction, if it materialises, will likely be secondary in nature, enabling Siguler Guff to partially or fully exit. A smaller primary infusion may also be included to fund Relisys's expansion plans, said the second person. Both private equity firms are expected to seek a controlling stake in the Hyderabad-based medical devices maker. In secondary deals, existing shareholders sell their stakes to other investors and the company doesn't receive any new capital. Such shares are usually traded at a discount to primary equity. While KKR declined to comment, TPG, Siguler Guff, Healthium, and Relisys did not respond to Mint's mails sent on Sunday. Also read: Zydus bets big on vaccines and medtech In February, VCCircle had reported that o3 Capital, a mid-market investment bank, was advising Relisys in its search for potential buyers. The report also noted that existing investor Siguler Guff was exploring a full or partial exit, alongside the company's founders, in a transaction then estimated to be valued at $50–70 million ( ₹435–610 crore). Company background Founded in 1997 by technocrats and clinicians, Relisys Medical Devices manufactures cardiovascular products like drug-eluting stents, balloon catheters, diagnostic catheters, and transcatheter heart valves. It also acquired Multimedics in 2018 to expand its stent-making capabilities globally. In FY24, the company reported revenue of ₹169.4 crore, up slightly from ₹162.7 crore a year earlier. Net profit rose marginally to ₹36.3 crore, according to data from Tracxn. The bustling deal activity in the sector also underscores the growing investor appetite for med-tech companies in India. Some notable transactions include Meril Life Sciences $210 million funding from Warburg Pincus which also invested about $300 million in Appasamy Associates. SMT raised $150 million from Samara Capital while Translumina raised around $90 million from Everstone Capital. Also read: Health ministry to set up a panel to review medical device-related adverse events Sector outlook India's $12 billion med-tech market is projected to hit $50 billion by 2030, according to EY. Despite $3.8 billion in exports last fiscal, the country is still heavily import-dependent, with imports at $8.2 billion, making up 80–85% of domestic consumption. Growth is expected to be driven by rising income levels, wider insurance coverage, medical tourism, and rapid healthcare infrastructure expansion in Tier 2 and 3 cities. EY noted that global MNCs are increasingly choosing India for R&D, manufacturing, and global capability centers (GCCs)—further strengthening the ecosystem. Also read: India eyes global pharma dominance with a ₹5,000 crore revitalisation plan

Apollo Hospitals plans to sell maternity care arm
Apollo Hospitals plans to sell maternity care arm

Time of India

time11 hours ago

  • Time of India

Apollo Hospitals plans to sell maternity care arm

Apollo Hospitals Enterprises, India's largest private hospital chain, plans to sell Apollo Cradle and Children's Hospital (ACCHL), a chain of maternity and infant care hospitals , multiple people familiar with the development said. Apollo has hired Allegro Capital to find a buyer for the asset, which is likely to be valued at ₹1,000-1,200 crore, they said. The sale process has been launched and the banker has sounded out to a bunch of leading private equity funds . An email sent to Apollo Hospitals spokesperson for comments on Friday did not elicit any responses till the press time on Sunday. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Schlechter Stuhlgang? Diese Methode funktioniert wie "auf Knopfdruck" Darmschutz Ratgeber Undo ACCHL, a subsidiary of Apollo Specialty Hospitals, has about 363 beds under 13 hospitals across cities like Delhi, Bengaluru, Chennai, Hyderabad, Amritsar, Gurugram, Noida and Ghaziabad. For the year ended March 2024, ACCHL recorded a net loss of ₹17 lakh, according to Apollo's annual report. The mother and child care market in India is estimated at about ₹30,000 crore a year and is expected to grow 15% compounded annually over the next few years. The market is currently dominated by a handful of private hospitals such as Apollo Cradle, Hyderabad-based Rainbow Children's Medicare , and Bengaluru-based chains Motherhood, Cloudnine Hospitals and Kangaroo Care. Live Events British International Investment Plc-backed Rainbow got listed in 2022 and has a market cap of ₹14,260 crore as of Friday. Motherhood is backed by TPG Growth and Singapore's GIC, while Cloudnine is backed by domestic PE fund True North, TPG NewQuest, Temasek and Peak XV. Indira IVF, the country's largest fertility clinics chain owned by EQT Partners, entered into maternity and childcare with the launch of MatCare Maternity & Child Hospital in March. Private equity firm SeaLink Capital Partners and the promoters of Surya Children's Medicare are, meanwhile, looking to sell a majority stake in western India's largest children's hospital chain. A deal is expected to value the company at ₹1,000-1,200 crore, ET reported last year. As of March 31, 2024, Apollo Hospitals had a capacity of 10,134 beds across 73 hospitals in India and overseas. Of these, 8,710 beds are located in 45 owned hospitals, 271 beds in 11 daycare/short surgical stay centres, and 790 beds in six hospitals under management through operations and management contracts.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store